Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | %Female (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69 | Clinical Dermatology: Retinoids and other Treatments | journal | 0.101 Q4 | 3 | 15 | 49 | 94 | 1 | 34 | 0.03 | 6.27 | 50.00 | |
68 | Drugs and Therapy Perspectives | journal | 0.101 Q4 | 13 | 71 | 235 | 1230 | 4 | 225 | 0.01 | 17.32 | 50.00 | |
67 | Signal | journal | 0.102 Q4 | 1 | 0 | 12 | 0 | 0 | 10 | 0.00 | 0.00 | 0.00 | |
66 | Journal of Clinical Research | journal | 0.129 Q3 | 12 | 2 | 6 | 23 | 1 | 6 | 0.25 | 11.50 | 66.67 | |
65 | MeReC Bulletin | journal | 0.132 Q3 | 7 | 1 | 28 | 12 | 5 | 27 | 0.17 | 12.00 | 0.00 | |
64 | MeReC Extra | journal | 0.133 Q3 | 2 | 14 | 29 | 53 | 4 | 14 | 0.15 | 3.79 | 0.00 | |
63 | Pharmacy in Practice | journal | 0.141 Q3 | 6 | 26 | 173 | 313 | 5 | 148 | 0.03 | 12.04 | 63.64 | |
62 | Therapy | journal | 0.144 Q3 | 22 | 99 | 257 | 4351 | 112 | 220 | 0.44 | 43.95 | 28.06 | |
61 | Klinik Psikofarmakoloji Bulteni | journal | 0.147 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
60 | Pharmaceutical Medicine | journal | 0.149 Q3 | 25 | 36 | 141 | 566 | 52 | 126 | 0.40 | 15.72 | 36.67 | |
59 | Clinical Pharmacist | journal | 0.150 Q3 | 11 | 108 | 0 | 478 | 0 | 0 | 0.00 | 4.43 | 52.86 | |
58 | Expert Review of Clinical Pharmacology | journal | 0.151 Q3 | 60 | 58 | 71 | 5034 | 32 | 61 | 0.45 | 86.79 | 36.70 | |
57 | Drug and Therapeutics Bulletin | journal | 0.159 Q3 | 17 | 51 | 78 | 955 | 34 | 78 | 0.43 | 18.73 | 0.00 | |
56 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 0.186 Q3 | 8 | 0 | 56 | 0 | 19 | 56 | 0.00 | 0.00 | 0.00 | |
55 | Future HIV Therapy | journal | 0.191 Q3 | 8 | 0 | 57 | 0 | 20 | 46 | 0.35 | 0.00 | 0.00 | |
54 | PharmacoEconomics - Italian Research Articles | journal | 0.214 Q3 | 9 | 21 | 40 | 406 | 16 | 31 | 0.48 | 19.33 | 32.61 | |
53 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.247 Q3 | 61 | 69 | 195 | 2369 | 96 | 172 | 0.57 | 34.33 | 42.02 | |
52 | Journal of Oncology Pharmacy Practice | journal | 0.323 Q3 | 44 | 34 | 91 | 861 | 88 | 84 | 0.81 | 25.32 | 39.66 | |
51 | Biopharmaceutics and Drug Disposition | journal | 0.369 Q2 | 65 | 52 | 164 | 1637 | 263 | 164 | 1.46 | 31.48 | 33.48 | |
50 | Journal of Chemotherapy | journal | 0.393 Q2 | 56 | 131 | 448 | 3318 | 459 | 401 | 1.15 | 25.33 | 40.93 | |
49 | European Journal of Contraception and Reproductive Health Care | journal | 0.410 Q2 | 53 | 63 | 178 | 1362 | 189 | 165 | 1.09 | 21.62 | 59.79 | |
48 | Therapeutic Advances in Respiratory Disease | journal | 0.490 Q2 | 50 | 34 | 44 | 1571 | 83 | 41 | 1.89 | 46.21 | 33.90 | |
47 | Therapeutic Advances in Cardiovascular Disease | journal | 0.512 Q2 | 41 | 43 | 55 | 2499 | 97 | 49 | 1.76 | 58.12 | 20.29 | |
46 | Clinical Drug Investigation | journal | 0.513 Q2 | 67 | 93 | 252 | 2659 | 472 | 244 | 1.79 | 28.59 | 32.87 | |
45 | International Journal of STD and AIDS | journal | 0.542 Q2 | 78 | 247 | 751 | 4520 | 882 | 651 | 1.12 | 18.30 | 42.54 | |
44 | BMC Clinical Pharmacology | journal | 0.599 Q2 | 43 | 19 | 34 | 679 | 84 | 34 | 2.46 | 35.74 | 39.22 | |
43 | Expert Opinion on Pharmacotherapy | journal | 0.613 Q2 | 93 | 271 | 794 | 20462 | 1915 | 773 | 2.52 | 75.51 | 31.12 | |
42 | BMC Pharmacology | journal | 0.620 Q2 | 48 | 19 | 53 | 530 | 96 | 53 | 1.41 | 27.89 | 27.03 | |
41 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.622 Q2 | 81 | 90 | 264 | 2551 | 578 | 242 | 2.03 | 28.34 | 34.66 | |
40 | Acta Pharmacologica Sinica | journal | 0.624 Q2 | 117 | 199 | 659 | 8200 | 1233 | 657 | 1.81 | 41.21 | 41.71 | |
39 | Paediatric Drugs | journal | 0.700 Q2 | 70 | 52 | 137 | 2363 | 324 | 108 | 2.42 | 45.44 | 34.41 | |
38 | Fundamental and Clinical Pharmacology | journal | 0.707 Q2 | 85 | 90 | 228 | 3924 | 546 | 222 | 2.37 | 43.60 | 35.31 | |
37 | Drugs and Aging | journal | 0.749 Q2 | 109 | 90 | 248 | 5633 | 659 | 236 | 3.01 | 62.59 | 39.12 | |
36 | Human Psychopharmacology | journal | 0.758 Q2 | 86 | 75 | 212 | 3679 | 540 | 204 | 2.56 | 49.05 | 32.92 | |
35 | Expert Review of Neurotherapeutics | journal | 0.775 Q2 | 98 | 147 | 519 | 13586 | 1289 | 466 | 2.49 | 92.42 | 30.00 | |
34 | Expert Opinion on Drug Safety | journal | 0.779 Q2 | 90 | 68 | 240 | 5545 | 673 | 192 | 2.84 | 81.54 | 27.71 | |
33 | American Journal of Cardiovascular Drugs | journal | 0.796 Q2 | 60 | 43 | 134 | 2160 | 338 | 128 | 2.63 | 50.23 | 24.24 | |
32 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 | 40.48 | |
31 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.848 Q2 | 57 | 38 | 98 | 1324 | 219 | 94 | 2.27 | 34.84 | 32.14 | |
30 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 | 26.23 | |
29 | HIV Clinical Trials | journal | 0.888 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
28 | Expert Review of Anticancer Therapy | journal | 0.895 Q2 | 85 | 166 | 539 | 11461 | 1262 | 492 | 2.40 | 69.04 | 26.58 | |
27 | Cardiovascular Therapeutics | journal | 0.927 Q1 | 54 | 37 | 32 | 1698 | 93 | 28 | 2.91 | 45.89 | 21.85 | |
26 | Journal of Biomedical Science | journal | 0.982 Q1 | 110 | 113 | 234 | 5075 | 558 | 230 | 2.23 | 44.91 | 38.85 | |
25 | PLoS Clinical Trials | journal | 1.017 Q1 | 14 | 0 | 25 | 0 | 65 | 22 | 2.71 | 0.00 | 0.00 | |
24 | Trials | journal | 1.088 Q1 | 98 | 124 | 139 | 4196 | 334 | 131 | 2.36 | 33.84 | 33.62 | |
23 | AIDS Research and Therapy | journal | 1.112 Q1 | 49 | 30 | 82 | 891 | 210 | 82 | 2.81 | 29.70 | 35.24 | |
22 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | 38.36 | |
21 | British Journal of Clinical Pharmacology | journal | 1.187 Q1 | 167 | 216 | 725 | 6383 | 2305 | 558 | 3.02 | 29.55 | 34.18 | |
20 | CNS Drugs | journal | 1.217 Q1 | 129 | 86 | 250 | 6860 | 1085 | 221 | 4.47 | 79.77 | 34.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®